| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 30,000 | $20.85 | $625,500.00 | -4.9% | +2.1% | -74.3% | |
| Dec 1, 2022 | STE Steris Plc | Majors Cary L54 | SVP And President, Healthcare | Sell | 1,600 | $192.51 | $308,016.00 | -11.4% | -2.0% | +5.8% | |
| Dec 1, 2022 | ARAY Accuray Inc | Hoge Michael68 | Senior VP Global Operations | Sell | 5,531 | $2.10 | $11,592.98 | -1.9% | +36.7% | +21.0% | |
| Dec 1, 2022 | PACB Pacific Biosciences Of California, Inc. | Henry Christian O78 | See Remarks | Sell | 45,000 | $10.84 | $487,980.00 | -6.5% | -20.8% | -19.9% | |
| Dec 1, 2022 | Huller Kelly58 | SVP, GC, Corporate Secretary | Sell | 7,500 | $75.00 | $562,500.75 | -100% | -23.3% | -39.1% | ||
| Dec 1, 2022 | LUNG Pulmonx Corp | Lehman David Aaron79 | General Counsel | Sell | 1,069 | $5.93 | $6,339.17 | -1.2% | +87.0% | +82.9% | |
| Dec 1, 2022 | LUNG Pulmonx Corp | Sung Derrick81 | Chief Financial Officer | Sell | 1,069 | $5.93 | $6,339.17 | -0.2% | +87.0% | +82.9% | |
| Dec 1, 2022 | IDXX Idexx Laboratories Inc /de | Turner Kathy V62 | Senior Vice President | Sell | 3,000 | $436.00 | $1,308,000.00 | -30.2% | +6.8% | +9.9% | |
| Dec 1, 2022 | LUNG Pulmonx Corp | French Glendon E. III84 | President And CEO | Sell | 3,631 | $5.93 | $21,531.83 | -0.2% | +87.0% | +82.9% | |
| Dec 1, 2022 | ARAY Accuray Inc | Spine Patrick62 | SVP, Chief Admin Officer | Sell | 5,176 | $2.10 | $10,848.90 | -2.4% | +36.7% | +21.0% | |
| Dec 1, 2022 | LMAT Lemaitre Vascular Inc | Roush John A49 | Director | Sell | 7,500 | $46.65 | $349,840.50 | -48.2% | +6.0% | +13.5% | |
| Dec 1, 2022 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 10,000 | $61.30 | $613,026.35 | -46.6% | +31.7% | +20.9% | |
| Dec 1, 2022 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 1,500 | $210.29 | $315,431.00 | -0.5% | +23.0% | +8.4% | |
| Dec 1, 2022 | ITGR Integer Holdings Corp | Bailey Pamela G | Director | Sell | 7,018 | $74.06 | $519,746.06 | -12.4% | +3.3% | +19.7% | |
| Dec 1, 2022 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 95,000 | $22.35 | $2,122,800.00 | -3.2% | -14.7% | -62.3% | |
| Dec 1, 2022 | HBIO Harvard Bioscience Inc | Green James W70 | Chief Executive Officer | Buy | 30,000 | $2.51 | $75,300.00 | +0.7% | -1.8% | +58.8% | |
| Nov 30, 2022 | HOLX Hologic Inc | MacMillan Stephen P54 | Chairman, President And CEO | Sell | 33,500 | $75.65 | $2,534,364.59 | -0.7% | +4.6% | -6.4% | |
| Nov 30, 2022 | HYPR Hyperfine, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Buy | 229,215 | $0.82 | $187,956.30 | +34.9% | +101.3% | +60.0% | |
| Nov 30, 2022 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 12,761 | $20.34 | $259,497.49 | -29.1% | +8.2% | -75.1% | |
| Nov 30, 2022 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 2,250 | $2.35 | $5,280.53 | -1.9% | - | - | |
| Nov 30, 2022 | ITGR Integer Holdings Corp | Bolt Jennifer M | EVP, Global Operations &Esg | Sell | 1,000 | $71.16 | $71,160.00 | -4.2% | +0.9% | +17.4% | |
| Nov 30, 2022 | BLFS Biolife Solutions Inc | De Greef Roderick74 | COO &President | Sell | 45,405 | $20.69 | $939,629.95 | -15.5% | +9.9% | -41.6% | |
| Nov 30, 2022 | POCI Precision Optics Corporation, Inc. | Anania Peter V. | Director | Buy | 332 | $6.00 | $1,992.00 | +3.9% | +23.5% | +3.3% | |
| Nov 29, 2022 | LUNG Pulmonx Corp | Lynch Alissa Hsu | Director | Buy | 1,700 | $5.51 | $9,367.00 | +16.7% | +105.8% | +106.6% | |
| Nov 29, 2022 | HYPR Hyperfine, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Buy | 47,007 | $0.72 | $33,845.04 | +7.7% | +80.5% | +63.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.